Antihypertensive ACE inhibitors have successfully been used in the treatment of severe COVID-19 [205,209], and multiple clinical trials suggesting that Ang(1-7) can be used to treat COVID-19 are ongoing (see https://clinicaltrials.gov/ct2/show/NCT04332666, accessed on 5 June 2021, https://www.clinicaltrials.gov/ct2/show/NCT04401423, accessed on 5 June 2021 and https://clinicaltrials.gov/ct2/show/NCT04375124, accessed on 5 June 2021). This evidence concerns the gene ANG and COVID-19.